Drug Recall
-
{
- All
- News
-
Cipla, Glenmark Recall Asthma Drugs Made In Indore From US Market
Drug makers Cipla and Glenmark are recalling products from the American market due to manufacturing issues, according to the US health regulator.
-
Why Sun Pharma Shares are Down 8% in 4 Days
According to reports, the drugmaker's US subsidiary Taro has recalled a blood clot drug because it reportedly did not meet US Food and Drug Administration standards.
-
Sun Pharma Recalls Over 40,000 Bottles of Antidepressant in US
Sun Pharmaceutical Industries Ltd is recalling 41,127 bottles of antidepressant venlafaxine hydrochloride in the United States after the drug failed to dissolve properly, the US Food and Drug Administration (FDA) said.
-
Sun Pharma Recalls Over 4 Lakh Bottles of 2 Drugs in US: Report
Drug major Sun Pharmaceuticals is recalling over 4 lakh bottles of anti-depressant and anti-allergy drugs in the US for failing to meet specifications.
-
Biocon Recalls 3,665 Bottles Of Antifungal Drug In US For "Failed Specifications"
Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
Lupin, Zydus Pharmaceuticals Recall Products In U.S.
U.S. FDA has initiated a Class III recall, which means exposure to the drugs is not likely to result in any adverse consequences.
-
Lupin Recalls Over 12,000 Cartons Of Birth Control Tablets From U.S. Market
The voluntary ongoing nationwide recall is a class-II recall, says a U.S. FDA report.
-
Lupin Recalls Over 12,000 Cartons Of Birth Control Tablets From U.S. Market
The voluntary ongoing nationwide recall is a class-II recall, says a U.S. FDA report.
-
Lupin, Sun Pharma, Glenmark Recall Products In The U.S.
Indian drugmakers Lupin, Sun Pharma, and Glenmark are recalling various drugs from the U.S. market for a variety of reasons.
-
Pfizer’s Hospital-Drug Problems Won’t Go Away
Investors have mostly been willing to hold their nose over Hospira as Pfizer’s stock surged this year.
-
Sun Pharma Recalls 5,214 Units Of Testosterone Cypionate Injections In U.S.
Recall was due to “presence of particulate matter: organic and inorganic compounds detected in vials of product, says U.S. FDA.
-
Sun Pharma Recalls 5,214 Units Of Testosterone Cypionate Injections In U.S.
Recall was due to “presence of particulate matter: organic and inorganic compounds detected in vials of product, says U.S. FDA.
-
Dr. Reddy’s Recalls 2.36 Lakh Bottles Of Cholesterol Lowering Tablets From U.S.
Dr. Reddy’s is recalling the tablets on account of “failed impurities/degradation specifications” the U.S.FDA said.
-
Dr Reddy's, Aurobindo Pharma Recall Some Drugs From US Market, Says Regulator
Dr Reddy's is recalling Olanzapine tablets USP of 2.5 mg while Aurobindo is recalling Pantoprazole Sodium for Injection, 40mg per vial from the market, the notification issued by the US regulator said.
-
Cipla, Glenmark Recall Asthma Drugs Made In Indore From US Market
Drug makers Cipla and Glenmark are recalling products from the American market due to manufacturing issues, according to the US health regulator.
-
Why Sun Pharma Shares are Down 8% in 4 Days
According to reports, the drugmaker's US subsidiary Taro has recalled a blood clot drug because it reportedly did not meet US Food and Drug Administration standards.
-
Sun Pharma Recalls Over 40,000 Bottles of Antidepressant in US
Sun Pharmaceutical Industries Ltd is recalling 41,127 bottles of antidepressant venlafaxine hydrochloride in the United States after the drug failed to dissolve properly, the US Food and Drug Administration (FDA) said.
-
Sun Pharma Recalls Over 4 Lakh Bottles of 2 Drugs in US: Report
Drug major Sun Pharmaceuticals is recalling over 4 lakh bottles of anti-depressant and anti-allergy drugs in the US for failing to meet specifications.
-
Biocon Recalls 3,665 Bottles Of Antifungal Drug In US For "Failed Specifications"
Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
Lupin, Zydus Pharmaceuticals Recall Products In U.S.
U.S. FDA has initiated a Class III recall, which means exposure to the drugs is not likely to result in any adverse consequences.
-
Lupin Recalls Over 12,000 Cartons Of Birth Control Tablets From U.S. Market
The voluntary ongoing nationwide recall is a class-II recall, says a U.S. FDA report.
-
Lupin Recalls Over 12,000 Cartons Of Birth Control Tablets From U.S. Market
The voluntary ongoing nationwide recall is a class-II recall, says a U.S. FDA report.
-
Lupin, Sun Pharma, Glenmark Recall Products In The U.S.
Indian drugmakers Lupin, Sun Pharma, and Glenmark are recalling various drugs from the U.S. market for a variety of reasons.
-
Pfizer’s Hospital-Drug Problems Won’t Go Away
Investors have mostly been willing to hold their nose over Hospira as Pfizer’s stock surged this year.
-
Sun Pharma Recalls 5,214 Units Of Testosterone Cypionate Injections In U.S.
Recall was due to “presence of particulate matter: organic and inorganic compounds detected in vials of product, says U.S. FDA.
-
Sun Pharma Recalls 5,214 Units Of Testosterone Cypionate Injections In U.S.
Recall was due to “presence of particulate matter: organic and inorganic compounds detected in vials of product, says U.S. FDA.
-
Dr. Reddy’s Recalls 2.36 Lakh Bottles Of Cholesterol Lowering Tablets From U.S.
Dr. Reddy’s is recalling the tablets on account of “failed impurities/degradation specifications” the U.S.FDA said.
-
Dr Reddy's, Aurobindo Pharma Recall Some Drugs From US Market, Says Regulator
Dr Reddy's is recalling Olanzapine tablets USP of 2.5 mg while Aurobindo is recalling Pantoprazole Sodium for Injection, 40mg per vial from the market, the notification issued by the US regulator said.
